The enzyme linked immunosorbent assay (ELISA) is a biomedical detection technique that uses antibodies directed against a specific antigen. It allows detection and quantification of solid, liquid, or gaseous substances. ELISA techniques are widely used in fields including research, forensics, clinical diagnosis and monitoring of autoimmune disorders.
The global Enzyme Linked Immunosorbent Assay Market is estimated to be valued at US$ 2118.92 in 2023 and is expected to exhibit a CAGR of 8.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Technological advancements are expected to drive the growth of the enzyme linked immunosorbent assay market. Continuous developments in immunodiagnostics tools have led to the introduction of high-throughput ELISA techniques with improved sensitivity and specificity. Researchers are focusing on developing methods for ultrasensitive detection of extremely low-abundance targets. In addition, emergence of innovative digital ELISA techniques offering simpler protocols, faster results, and quantitative analysis is supporting market growth. New technologies such as electrochemiluminescence and chemiluminescence ELISAs can enhance signal generation for increased sensitivity. Growing integration of microfluidics and lab-on-a-chip technologies in ELISA devices is further expected to improve speed, cost-effectiveness, and convenience of assays. Such technological transformations are expanding applications of ELISA techniques across various industries.
Segment Analysis
The global Enzyme Linked Immunosorbent Assay market Growth is segmented on the basis of product, technology, application and end user. The product segment is dominating sub segment, which includes ELISA kits. ELISA kits holds the largest share in the market owing to increase usage of kits in research and development process among research organizations and academic institutes to detect antibodies, proteins in serum or plasma samples.
Key Takeaways
The global Enzyme Linked Immunosorbent Assay market is expected to witness high growth. The global Enzyme Linked Immunosorbent Assay Market is estimated to be valued at US$ 2118.92 in 2023 and is expected to exhibit a CAGR of 8.8% over the forecast period 2023-2030.
Regional analysis related content comprises The European region holds the largest share in ELISA market due to early adoption of advanced technologies and significant contribution in research and development activities in pharmaceutical and biotechnology companies across countries such as Germany, UK and France. The Asia Pacific region is expected to grow at fastest CAGR over the forecast period owing to increasing funding for research and development as well as presence of contract research organizations in countries like China and India.
Key players related content comprises Key players operating in the Enzyme Linked Immunosorbent Assay market are DSV, a.p. moller - maersk, United Parcel Service of America, Inc., XPO Logistics Inc., DHL International GmbH, Kuehne+Nagel Inc., Geodis, FedEx Corporation, C.H. Robinson Worldwide, Inc., db schenker. Key players adopt strategies such as expansions, mergers, acquisitions and new product launch to increase their market share and expand geographic presence. For instance, In February 2020, DSV completed acquisition of Panalpina to expand its services in air and sea freight forwarding.
Explore more related article on this topic: https://www.ukwebwire.com/the-global-enzyme-linked-immunosorbent-assay-market-growth/
The Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Research Report Forecast is a valuable source of insightful data for business strategists.
It provides the industry overview with recent trends, size, share, growth analysis, historical, futuristic data, revenue, demand and strategic development.The entire enzyme-linked immunosorbent assay (ELISA) testing market has been sub-categorized into test type and application.
The report provides an analysis of these subsets with respect to the geographical segmentation.
This research study will keep marketer informed and helps to identify the target demographics for a product or service.Request a FREE Sample Copy of Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Report with Full TOC At: https://www.valuemarketresearch.com/contact/enzyme-linked-immunosorbent-assay-elisa-testing-market/download-sampleBy Test TypeDirect ELISAIndirect ELISASandwich ELISACompetitive ELISABy ApplicationVaccine DevelopmentImmunologyDiagnosticsToxicologyDrug Monitoring & Pharmaceutical IndustryTransplantationBrowse Full Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Research Report With TOC At: https://www.valuemarketresearch.com/report/enzyme-linked-immunosorbent-assay-elisa-testing-marketThe research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the enzyme-linked immunosorbent assay (ELISA) testing market include Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., ALPCO, BioLegand, Inc., Enzo Life Sciences, Inc., Zeus Scientific, Inc., Shenzen YHLO Biotech Co. Ltd., Ortho-Clinical Diagnostics, Inc., R & D Systems Inc., BD Biosciences.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.This section covers regional segmentation which accentuates on current and future demand for enzyme-linked immunosorbent assay (ELISA) testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
